| Financial Year |
March 31 2023 |
| Monetary Funds |
24,340,886.06 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
112,027,503.91 |
| Accounts Receivable |
32,835,044.47 |
| Advances to Suppliers |
5,160,319.27 |
| Other Receivables |
2,708,979.89 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
511,005,276.77 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,568,387.02 |
| Total Current Assets |
724,334,150.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
382,838,569.14 |
| Under-construction Projects |
1,171,996.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
116,463,283.46 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
40,064,932.41 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
26,144,054.40 |
| Deferred Income Tax Assets |
50,026,143.03 |
| Other Non-Current Assets |
11,270,982.82 |
| Sub-Total of Non-Current Assets |
680,796,293.29 |
| Total Assets |
1,405,130,443.76 |
| Short-Term Loans |
285,339,035.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
61,675,584.21 |
| Accounts Received In Advance |
5,205,723.68 |
| Employee Compensation Payable |
3,267,414.71 |
| Taxes Payable |
9,502,025.99 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
88,329,393.14 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,931,808.97 |
| Other Current Liabilities |
102,840,905.21 |
| Sub-Total of Current Liabilities |
587,486,926.62 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
69,495,684.44 |
| Deferred Income Tax Liabilities |
2,831,636.25 |
| Other Non-Current Liabilities |
10,000,000.00 |
| Sub-Total of Non-Current Liabilities |
133,812,986.96 |
| Total Liabilities |
721,299,913.58 |
| Paid-In Capital(Or Share Stock) |
332,749,154.00 |
| Capital Surplus |
574,754,618.03 |
| Surplus Reserve |
63,683,437.00 |
| LESS:Treasury Stock |
7,839,858.39 |
| Undistributed Profits |
-239,474,461.37 |
| Minority Stockholder's Interest |
104,679.93 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
683,725,850.25 |
| Owner's Equity（Stockholder's Equity） |
683,830,530.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,405,130,443.76 |
